Home › Funds › STEELHEAD PARTNERS LLC › BBIO

STEELHEAD PARTNERS LLC position in BBIO

BRIDGEBIO PHARMA INC · Health Care

STEELHEAD PARTNERS LLC reported holding 55,000,000 shares of BBIO (BRIDGEBIO PHARMA INC) in its Q3 2026 13F filing — a position valued at US$85.6M, representing 6.47% of its reported portfolio and ranking #6 among its reported holdings. STEELHEAD PARTNERS LLC has disclosed BBIO holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)55.00M sh
Reported value held$85.58M
Portfolio Weight6.47%
First reportedQ2 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How STEELHEAD PARTNERS LLC's BBIO position evolved

STEELHEAD PARTNERS LLC first disclosed a stake in BBIO in Q2 2026 at 70,000,000 shares (US$124.8M). Across 2 filings, STEELHEAD PARTNERS LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 55,000,000 shares valued at US$85.6M — a reduction of -15,000,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 70.00M $124.78M New
Q3 2026 55.00M $85.58M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BBIO and 13F data

BBIO (BRIDGEBIO PHARMA INC) is a Health Care company. 40 other funds we track also report a position in BBIO — the largest reported positions include Jupiter Topco LLC (US$1.05B), Janus Henderson Group (US$978.6M), Farallon Capital Management (US$800.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BBIO

All BBIO fund holders →

FAQ

How long has STEELHEAD PARTNERS LLC held BBIO?

STEELHEAD PARTNERS LLC has disclosed BBIO holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is STEELHEAD PARTNERS LLC's current position in BBIO?

As of Q3 2026, STEELHEAD PARTNERS LLC holds 55.00M shares of BBIO (BRIDGEBIO PHARMA INC), valued at $85.58M, representing 6.47% of its reported portfolio and ranking #6.

Has STEELHEAD PARTNERS LLC been buying or selling BBIO?

In the latest 13F filing (Q3 2026), STEELHEAD PARTNERS LLC reduced its position in BBIO.

Which other funds hold BBIO?

Other major institutional holders of BBIO include Jupiter Topco LLC, Janus Henderson Group, Farallon Capital Management, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.